Home › Targets › TTR

TTR (1 companies · 4 programs)

Companies with an active program directed at TTR.

Intellia Therapeutics, Inc. NTLA

nex-z — Transthyretin Amyloidosis with Cardiomyopathy Phase 3
nex-z — Hereditary Transthyretin Amyloidosis with Polyneuropathy Phase 3
nexiguran ziclumeran — ATTR Amyloidosis with Cardiomyopathy Phase 3
nexiguran ziclumeran — Hereditary ATTR Amyloidosis with Polyneuropathy Phase 3